Quadrivalent Influenza Vaccine, MF-59 Adjuvanted
N/A
Report date: 2026/05/24 20:00:34
Base Information
Drug NameQuadrivalent Influenza Vaccine, MF-59 Adjuvanted
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2020/02/21
Country/Territory +[6]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeqirus Usa Inc
China Registration ClassN/A
Develop Information
Active CompaniesSeqirusSeqirus Usa Inc
Inactive CompaniesSeqirus Netherlands Bv
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A